RITUXIMAB IN PRIMARY CNS LYMPHOMA-LONG TERM FOLLOW-UP OF THE PHASE III HOVON 105/ALLG NHL 24 STUDY

J. E. C. Bromberg; S. Issa; B. van der Holt; M. C. Minnema; T. Seute; M. F. Durian; G. Cull; M. W. M. van der Poel; W. B. C. Stevens; J. M. Zijlstra; M. Nijland; K. D. Mason; A. Beeker; D. Brandsma; M. J. van den Bent; M. Gonzalez; Djanick de Jong; J. K. Doorduijn

RITUXIMAB IN PRIMARY CNS LYMPHOMA-LONG TERM FOLLOW-UP OF THE PHASE III HOVON 105/ALLG NHL 24 STUDY

J. E. C. Bromberg, S. Issa, B. van der Holt, M. C. Minnema, T. Seute, M. F. Durian, G. Cull, M. W. M. van der Poel, W. B. C. Stevens, J. M. Zijlstra, M. Nijland, K. D. Mason, A. Beeker, D. Brandsma, M. J. van den Bent, M. Gonzalez, Djanick de Jong, J. K. Doorduijn

Internal Medicine

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

Original language	English
Number of pages	2
Journal	Neuro-Oncology
Volume	24
Publication status	Published - 5 Sept 2022
Event	17th Meeting of the European-Association-of-Neuro-Oncology - Vienna, Austria Duration: 15 Sept 2022 → 18 Sept 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Bromberg, J. E. C., Issa, S., van der Holt, B., Minnema, M. C., Seute, T., Durian, M. F., Cull, G., van der Poel, M. W. M., Stevens, W. B. C., Zijlstra, J. M., Nijland, M., Mason, K. D., Beeker, A., Brandsma, D., van den Bent, M. J., Gonzalez, M., de Jong, D., & Doorduijn, J. K. (2022). RITUXIMAB IN PRIMARY CNS LYMPHOMA-LONG TERM FOLLOW-UP OF THE PHASE III HOVON 105/ALLG NHL 24 STUDY. Neuro-Oncology, 24.

@article{16d35f23e6ab4ae9b7dc04c77a2d9b15,

title = "RITUXIMAB IN PRIMARY CNS LYMPHOMA-LONG TERM FOLLOW-UP OF THE PHASE III HOVON 105/ALLG NHL 24 STUDY",

author = "Bromberg, \{J. E. C.\} and S. Issa and \{van der Holt\}, B. and Minnema, \{M. C.\} and T. Seute and Durian, \{M. F.\} and G. Cull and \{van der Poel\}, \{M. W. M.\} and Stevens, \{W. B. C.\} and Zijlstra, \{J. M.\} and M. Nijland and Mason, \{K. D.\} and A. Beeker and D. Brandsma and \{van den Bent\}, \{M. J.\} and M. Gonzalez and \{de Jong\}, Djanick and Doorduijn, \{J. K.\}",

year = "2022",

month = sep,

day = "5",

language = "English",

volume = "24",

journal = "Neuro-Oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

note = "17th Meeting of the European-Association-of-Neuro-Oncology ; Conference date: 15-09-2022 Through 18-09-2022",

}

TY - JOUR

T1 - RITUXIMAB IN PRIMARY CNS LYMPHOMA-LONG TERM FOLLOW-UP OF THE PHASE III HOVON 105/ALLG NHL 24 STUDY

AU - Bromberg, J. E. C.

AU - Issa, S.

AU - van der Holt, B.

AU - Minnema, M. C.

AU - Seute, T.

AU - Durian, M. F.

AU - Cull, G.

AU - van der Poel, M. W. M.

AU - Stevens, W. B. C.

AU - Zijlstra, J. M.

AU - Nijland, M.

AU - Mason, K. D.

AU - Beeker, A.

AU - Brandsma, D.

AU - van den Bent, M. J.

AU - Gonzalez, M.

AU - de Jong, Djanick

AU - Doorduijn, J. K.

PY - 2022/9/5

Y1 - 2022/9/5

UR - http://10.1093/neuonc/noac174.038

M3 - Abstract/Meeting Abstract

SN - 1522-8517

VL - 24

JO - Neuro-Oncology

JF - Neuro-Oncology

T2 - 17th Meeting of the European-Association-of-Neuro-Oncology

Y2 - 15 September 2022 through 18 September 2022

ER -

RITUXIMAB IN PRIMARY CNS LYMPHOMA-LONG TERM FOLLOW-UP OF THE PHASE III HOVON 105/ALLG NHL 24 STUDY

UN SDGs

Other files and links

OS03.6.A Rituximab in primary CNS lymphoma - long term follow-up of the phase III HOVON 105/ALLG NHL 24 Study

Cite this